IMPACT OF BARIATRIC SURGERY ON OBESITY AND TYPE 2 DIABETES

IMPACT OF BARIATRIC SURGERY ON OBESITY AND TYPE 2 DIABETES

Authors

  • TAMAR SHERVASHIDZE David Agmashenebeli University of Georgia image/svg+xml
  • RUSUDAN KVANCHAKHADZE David Agmashenebeli University of Georgia image/svg+xml
  • DAVID ABULADZE Davit Abuladze Georgian-Italian Clinic
  • LIA JASHI "Avicena" Batumi Medical University
  • MIRANDA SHERVASHIDZE Batumi Shota Rustaveli State University image/svg+xml

DOI:

https://doi.org/10.52340/jecm.2024.05.11

Keywords:

Bariatric surgery, Diabetes mellitus, Obesity, Type 2 diabetes

Abstract

Obesity is the most common preventable metabolic change in recent decades. The main cause of obesity is a long-term imbalance between energy consumption and expenditure. Obesity causes chronic, systemic inflammation, which may lead to increased insulin resistance (IR), β-cell dysfunction, and ultimately type 2 diabetes mellitus (T2D). In high-risk patients with prediabetes and/or metabolic syndrome, weight loss effectively prevents progression to type 2 diabetes mellitus (T2DM). Bariatric surgery is the most frequently used and effective intervention for the treatment of obesity, which is accompanied by improvement in metabolic and comorbidities. Multifaceted effects of bariatric surgery have been established, including effects on intestinal physiology, neuronal transmission, incretin secretion, bile acid metabolism, and changes in the microbiome. Bariatric surgery improves diabetes control through both weight-dependent and weight-independent mechanisms

Downloads

Download data is not yet available.

References

Koliaki C, Liatis S, le Roux CW, Kokkinos A. The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr Disord. 2017 Aug 10;17(1):50. doi: 10.1186/s12902-017-0202-6. PMID: 28797248;

Bassett DR Jr, Wyatt HR, Thompson H, Peters JC, Hill JO. Pedometer-measured physical activity and health behaviors in U.S. adults. Med Sci Sports Exerc. 2010 Oct;42(10):1819-25. doi: 10.1249/MSS.0b013e3181dc2e54.

Rolls BJ, Roe LS, Beach AM, Kris-Etherton PM. Provision of foods differing in energy density affects long-term weight loss. Obes Res. 2005 Jun;13(6):1052-60. doi: 10.1038/oby.2005.123. PMID: 15976148.

Smith KB, Smith MS. Obesity Statistics. Prim Care. 2016 Mar;43(1):121-35, ix. doi: 10.1016/j.pop.2015.10.001. Epub 2016 Jan 12. PMID: 26896205.

Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected - obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol. 2021 Mar;17(3):135-149. doi: 10.1038/s41574-020-00462-1. Epub 2021 Jan 21.

Vulcano E, Lee YY, Yamany T, Lyman S, Valle AG. Obese patients undergoing total knee arthroplasty have distinct preoperative characteristics: an institutional study of 4718 patients. J Arthroplasty. 2013 Aug;28(7):1125-9. doi: 10.1016/j.arth.2012.10.028. Epub 2013 Mar 21. PMID: 23523207.

Tavares A, Viveiros F, Cidade C, Maciel J. Cirurgia bariátrica: do passado ao século XXI [Bariatric surgery: epidemic of the XXI century]. Acta Med Port. 2011 Jan-Feb;24(1):111-6. Portuguese. Epub 2011 Feb 28. PMID: 21672448.

Puzziferri N, Roshek TB 3rd, Mayo HG, Gallagher R, Belle SH, Livingston EH. Long-term follow-up after bariatric surgery: a systematic review. JAMA. 2014 Sep 3;312(9):934-42. doi: 10.1001/jama.2014.10706. PMID: 25182102;

Jørgensen NB, Jacobsen SH, Dirksen C, Bojsen-Møller KN, Naver L, Hvolris L, Clausen TR, Wulff BS, Worm D, et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab. 2012 Jul 1;303(1):E122-31. doi: 10.1152/ajpendo.00073.2012. Epub 2012 Apr 24. PMID: 22535748

Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring). 2014 Jan;22(1):5-13. doi: 10.1002/oby.20662. PMID: 24307184;

Pournaras DJ, le Roux CW. Are bile acids the new gut hormones? Lessons from weight loss surgery models. Endocrinology. 2013 Jul;154(7):2255-6. doi: 10.1210/en.2013-1383. PMID: 23794408.

Regan JP, Inabnet WB, Gagner M, Pomp A. Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg. 2003 Dec;13(6):861-4. doi: 10.1381/096089203322618669. PMID: 14738671.

Jørgensen NB, Jacobsen SH, Dirksen C, Bojsen-Møller KN, Naver L, Hvolris L, Clausen TR, Wulff BS, et al. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance. Am J Physiol Endocrinol Metab. 2012 Jul 1;303(1):E122-31. doi: 10.1152/ajpendo.00073.2012. Epub 2012 Apr 24. PMID: 22535748.

Ferrannini E, Mingrone G. Impact of different bariatric surgical procedures on insulin action and beta-cell function in type 2 diabetes. Diabetes Care. 2009 Mar;32(3):514-20. doi: 10.2337/dc08-1762. PMID: 19246589;

Hainer V, Toplak H, Mitrakou A. Treatment modalities of obesity: what fits whom? Diabetes Care. 2008 Feb;31 Suppl 2:S269-77. doi: 10.2337/dc08-s265. PMID: 18227496.

Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013 Mar;273(3):219-34. doi: 10.1111/joim.12012. Epub 2013 Feb 8. PMID: 23163728.

Schauer PR, Bhatt DL, Kirwan JP, et al. STAMPEDE Investigators. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017 Feb 16;376(7):641-651. doi: 10.1056/NEJMoa1600869. PMID: 28199805; PMCID: PMC5451258.

Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg Obes Relat Dis. 2022 Dec;18(12):1345-1356. doi: 10.1016/j.soard.2022.08.013. Epub 2022 Oct 21. PMID: 36280539.

Miller KM, Foster NC, Beck RW, Bergenstal RM, DuBose SN, et al. T1D Exchange Clinic Network. Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry. Diabetes Care. 2015 Jun;38(6):971-8. doi: 10.2337/dc15-0078. PMID: 25998289.

Kirwan, J.P., Aminian, A., Kashyap, S.R., Burguera, B., Brethauer, S.A., & Schauer, P.R. (2016). Bariatric Surgery in Obese Patients With Type 1 Diabetes. Diabetes Care, 39, 941 - 948.

Fouse T, Schauer P. The Socioeconomic Impact of Morbid Obesity and Factors Affecting Access to Obesity Surgery. Surg Clin North Am. 2016 Aug;96(4):669-79. doi: 10.1016/j.suc.2016.03.002. PMID: 27473794.

Downloads

Published

2024-09-15

How to Cite

SHERVASHIDZE, T., KVANCHAKHADZE, R., ABULADZE, D., JASHI, L., & SHERVASHIDZE, M. (2024). IMPACT OF BARIATRIC SURGERY ON OBESITY AND TYPE 2 DIABETES. Experimental and Clinical Medicine Georgia, (5), 68–72. https://doi.org/10.52340/jecm.2024.05.11

Issue

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 > >> 

You may also start an advanced similarity search for this article.

Loading...